The expert panel asked for additional safety and immunogenicity data from the ongoing clinical trial in adult.
from Top India News- News18.com https://ift.tt/2V1y2KS
via Click here
from Top India News- News18.com https://ift.tt/2V1y2KS
via Click here
Comments
Post a Comment